• KAFM
  • Contact us
  • E-Submission

Korean J Fam Med : Korean Journal of Family Medicine

mobile search button mobile menu button
Search
Advanced Search
ABOUT
ARTICLE CATEGORY
BROWSE ARTICLES
AUTHOR INFORMATION

Articles

Page Path

Original Article

Effectiveness of a Pelvic Floor Muscle Exercise Intervention in Improving Knowledge, Attitude, Practice, and Self-Efficacy among Pregnant Women: A Randomized Controlled Trial

Parwathi Alagirisamy1orcid, Sherina Mohd Sidik2,3*orcid, Lekhraj Rampal1orcid, Siti Irma Fadhilah Ismail3orcid
Korean Journal of Family Medicine 2022;43(1):42-55.
Published online: January 20, 2022

1Department of Community Health, Faculty of Medicine and Health Science, Universiti Putra Malaysia, Serdang, Malaysia

2Cancer Resource & Education Center, Universiti Putra Malaysia, Serdang, Malaysia

3Department of Psychiatry, Faculty of Medicine & Health Sciences, Universiti Putra Malaysia, Serdang, Malaysia

*Corresponding Author: Sherina Mohd Sidik Tel: +60-3-9769 2530, Fax: +60-3-9769 2706, E-mail: sherina@upm.edu.my
• Received: January 5, 2021   • Revised: March 18, 2021   • Accepted: March 24, 2021

Copyright © 2022 The Korean Academy of Family Medicine

This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 5,697 Views
  • 250 Download
  • 5 Web of Science
  • 7 Crossref
  • 6 Scopus
prev next

Full Article

Download PDF Download PDF
  • Background
    The awareness and practice of pelvic floor muscle exercise (PFME) in the prevention and reduction of the rate of urinary incontinence among pregnant women was considerably poor, despite the increased prevalence of urinary incontinence during pregnancy across Malaysia. There healthcare providers do not give adequate attention to the potential impact of PFME on urinary incontinence and there is limited local intervention addressed urinary incontinence during pregnancy. The objective of this study was to determine the effectiveness of a newly developed PFME intervention in terms of knowledge, attitude, practice, self-efficacy, and urinary symptoms.
  • Methods
    A single-blinded, two-armed, randomized control trial was included pregnant women from 18 to 20 weeks of gestation and was conducted at the Maternity Hospital of Kuala Lumpur. The intervention group received PFME in addition to the usual perinatal care. The data were collected using validated questionnaires at 4 time points: baseline, post-intervention in the early third trimester, late third trimester, and early postnatal period. The intervention effects were analyzed using a generalized estimating equation.
  • Results
    The primary analysis included pregnant women who had at least one follow-up; 122 women (71.8%) in the intervention group had significant improvement in knowledge, attitude, practice, and self-efficacy, as well as in the severity of urinary incontinence over time. However, improvement was not observed in self-reported urinary incontinence.
  • Conclusion
    PFME can be considered an effective initial intervention to provide information about urinary incontinence prevention to pregnant women.
  • Keywords: Pelvic Floor; Exercise; Urinary Incontinence; Knowledge; Practice; Self-Efficacy
Urinary incontinence is a significant public health concern for women that not only affects the physical, psychological, and social aspects of a woman’s life, but is also associated with financial burden [1]. The time period of pregnancy in a woman’s life has long been established as the predisposing factor in the development of urinary incontinence, which potentially increases in prevalence throughout a lifetime or later in life [2]. Across Malaysia, prevalence of urinary incontinence increased between 34% and 85% during pregnancy over the past 5 years [3,4]. Despite this fact, there are limited continence status screenings during antenatal visits, and not all women are informed about the implications of urinary incontinence during pregnancy [4]; this is concerning and has an impact particularly for pregnant women who do not seek help for onset of urinary incontinence during pregnancy. This is due to unawareness of the fact that urinary incontinence during pregnancy is not a natural physiological change; indeed, it is a highly preventable and treatable condition [5,6]. Moreover, the literature reveals that the overall knowledge and practice of pelvic floor muscle exercise (PFME) remains poor among pregnant women in Malaysia [3,4,7]. Indeed, the delay in providing accurate and timely information concerning preventive strategies of urinary incontinence may hinder pregnant women from adopting preventive actions and interventions during pregnancy.
Contemporary research reviews have established PFME as a first-line preventive measure and as treatment for urinary incontinence during pregnancy and postpartum period, and it should be offered to all pregnant women in the early stage of their pregnancy, even in the absence of incontinence [8-10]. Although many studies have reported the effectiveness of antenatal PFME on urinary incontinence, few studies have addressed the effectiveness of PFME interventions on key behavioral change variables, including knowledge, attitude, practice, and self-efficacy. Moreover, the theoretical basis for PFME intervention is poorly defined, given the importance of behavioral changes in the success of PFME intervention in the prevention and management of urinary incontinence [11,12]. In response to the above issues, this study aims to develop, implement, and evaluate the effectiveness of a theory-driven PFME intervention on knowledge, attitude, practice, and self-efficacy of PFME, and to determine whether this intervention improves the continence status and severity of urinary symptoms among pregnant women.
1. Study Design
A single-blinded, two-armed randomized control trial (RCT) was conducted at the Maternity Hospital of Kuala Lumpur (MHKL), located in the central region of Kuala Lumpur. The MHKL is one of the largest and busiest maternity hospitals in Malaysia, and it serves as a tertiary referral center for government antenatal clinics, private hospitals, and private clinics in the region of the Klang Valley. The list of all pregnant women who attended the outpatient antenatal clinic in MHKL was assessed and those who were found to be eligible for the study served as the sampling frame. For each eligible pregnant woman who attended the antenatal clinic, research assistants randomly picked a card containing 170 odd numbers and 50 even numbers in which the pregnant women with an odd number drawn were selected for the study. This random selection process was continued until we reached the required sample size. Random selection was employed to ensure that each eligible pregnant woman in the sampling frame had an equal chance of being selected for the study.
The inclusion criteria of this study were pregnant women from 18 to 20 weeks of gestation, regardless of their continence status and parity, with a singleton pregnancy, and who had provided informed consent to participate in this study. Since the risk status of pregnancy is generally confirmed at 18 to 20 weeks of gestation, individuals were chosen who were in this period of gestation, and high-risk or complicated pregnancies were excluded from this study. Other exclusion criteria included the following: pregnant women aged <18 years, non-Malaysians, women undergoing physiotherapy treatment for severe urinary incontinence, previous urogenital surgery, and chronic medical disorders before pregnancy.
As the study included both categorical and continuous outcomes, the sample size was calculated for both outcomes. The sample size calculation was performed to achieve 80% power at the 5% level of significance and allowed 20% dropout for both categorical and continuous outcomes. For the primary outcome, there was no prevailing information of the intended outcome; therefore, the required sample size was estimated using a medium effect size of 0.50 based on effect size benchmarks suggested by Chow et al. [13] in 2008, and the total sample size was estimated to be 80 respondents per group. For the categorical outcome, the minimum required sample size was 85 respondents per group estimated using sample size formula comparing two proportions; meanwhile, n=(Zα/2+Zβ)2 ×[p1 (1-p1)+p2(1-p2)]/Є2 was used to detect 20% risk reduction in 34.3% of Malaysian pregnant women with urinary incontinence [3,8,13] A large sample size of 170 was selected for this study.
The randomization process was prepared in consultation with a biostatistician using a computer-generated stratified permuted block size of 6. Stratification was undertaken based on continence status and parity to ensure that respondents who were continent/incontinent and nulliparous (women in the first pregnancy)/multiparous were balanced across the intervention and control groups. After obtaining written informed consent forms and completion of the baseline assessments, the research assistants, who were blinded to block size, opened sequentially numbered opaque envelopes within each block corresponding to each stratum to allocate the selected respondents to either the intervention or control group. This process was continued until a total of 170 respondents were allocated to either group.
A single-blind method was used in which respondents were blinded to group allocation by promising that all respondents would obtain the intervention at different times; meanwhile, the respondents in the study were unaware that one group was a control group. Indeed, details of the intervention and control groups were not revealed in the consent forms or in the verbal clarification of the informed consent procedure. Further, to avoid potential contamination resulting from interaction between the respondents, all subjects were requested to withhold information of their participation in the studies. The intervention session was scheduled and held in a private meeting room.
2. Development of Pelvic Floor Muscle Exercise Intervention
The development of PFME interventions includes developing an intervention manual and information booklet. The content of the PFME intervention was based on six concepts of the Health Belief Model, which have been proposed as motivational elements to commence and adhere to PFME: perceived susceptibility, perceived severity, perceived benefits, perceived barriers, self-efficacy, and cues for action [12]. The Elicit-Provide-Elicit approach of Motivational Interviewing was used to provide information on PFME to enhance adherence to this intervention through active discussion among participants, educators, or clinicians [12,14]. The structure of the PFME intervention was designed based on the recommendations of Hay-Smith et al. [11], which includes education sessions, message reminders, and booster sessions. Table 1 displays the content and delivery of the interventions.
The intervention was validated in terms of quality control. Experts comprising senior consultants in Family Medicine, Public Health and Psychology from the Universiti Putra Malaysia (UPM) Faculty of Medicine and Health Sciences, and Physiotherapy at Hospital Kuala Lumpur reviewed the PFME intervention and provided qualitative suggestions with comments. These included the accuracy of the content, organization of information, application of the theory, relevance of the intervention, and comprehensibility. In response, the content of the intervention was revised and modified to meet the local context. The face validity of the intervention was supported by the findings of focus group discussions demonstrating that intervention users/physiotherapists and intervention recipients/pregnant women acknowledged and accepted the intervention.
The PFME intervention was pre-tested using a single-group prepost-test design among 30 pregnant women in MHKL who were not part of the main study using a convenience sampling method. The PFME intervention was delivered in a single session that focused predominantly on the education of the PFME intervention for the participants who were assessed on changes in knowledge and attitude at baseline and immediately post-intervention. The results of the pilot test indicated that the PFME intervention may be suitable for use in pregnant women, given that there was a significant improvement in PFME knowledge items ranging from 38.4% correct at baseline to 92.6% immediately post-intervention (P<0.001), and a favorable attitude towards PFME ranged from 75.8% at baseline to 98.4% immediately post-intervention (P=0.011).
The fidelity of the intervention was randomly checked by one observer, who was a senior breastfeeding educator. Additionally, the primary researcher, who was a physiotherapist, assisted in enhancing the consistency and reliability of the intervention.
3. Intervention Group
The intervention group received PFME in addition to the usual perinatal care. The first PFME education session was provided to a group of approximately 4–8 individuals for 35 to 40 minutes before 22 weeks of gestation. During this time, the primary researcher actively engaged in facilitating open discussion and provided information and demonstration of skills based on the PFME intervention manual. The respondents also received a copy of the PFME information booklet, along with a weekly short text message as a reminder to reinforce the practice of PFME over 8 weeks after the first session, as the first 8 weeks of PFME are crucial in the prevention and treatment of urinary incontinence [9]. This was followed by periodic individual and/or group booster sessions, with a duration of approximately 15–20 minutes at 4 weeks post first education session, early third trimester 28–30 weeks gestation, and late third trimester 36–38 weeks of gestations. These booster sessions specifically focused on reinforcing the skills and aims for targeted PFME, and on discussing experiences, challenges, and barriers in practicing PFME that helped to facilitate continuous practice of the intervention.
4. Control Group
The respondents allocated to the control group received the usual perinatal care at the MHKL. They also took part in standard hospital-based antenatal and postnatal education, which was normally offered to pregnant women in the late third trimester and during the hospitalized postnatal period. This education included a brief description of urinary incontinence and PFME.
5. Outcome Measurement
The primary outcome measures of knowledge, attitude, and practice of PFME were assessed using the Knowledge Attitude Practice (KAP) questionnaire, which was adapted and modified with the author’s permission in order to address all aspects of current PFME knowledge, attitudes, and practices that were related to urinary incontinence in our study population [7]. The original KAP questionnaire is available in both English and Malay, but only the English version has been validated. Changes made to the English version of the KAP questionnaire were then applied to the pre-existing Malay version of the questionnaire.
Categorical responses (true/false/don’t know) were applied for 18 knowledge questions and a correctly answered question was assigned a score of one point, while a score of zero was assigned for a wrong or “don’t know” answer. A 5-point Likert scale was used to measure the eight questions relating to the attitude towards PFME, in which each positive item was scored as either 1 (strongly disagree), 2 (disagree), 3 (neutral), 4 (agree), or 5 (strongly agree), and the scoring was reversed for any negative items. Using a 5-point Likert scale, five questions relating to PFME practice were rated: 1=never, 2=uncommon, 3=typically, 4=frequent, and 5=always.
For detection of the PFME self-efficacy primary outcome, the Self-Efficacy Scale for Practicing Pelvic Floor Exercises (SESPPFE) was used comprising of 17 questions with answers ranging from 0 (not confident at all) to 100 (the most confident) [15]. The final scores were obtained by calculating the mean of the items, ranging from 0 to 100, in which higher values were equivalent to higher self-efficacy in practicing PFME. The SESPPFE was translated into the Malay language using a standard forward-backward translation procedure.
The secondary outcome measures, such as continence status and severity of urinary incontinence, were measured using a validated Malay version questionnaire based on the International Consultation on Incontinence Questionnaire-Urinary Incontinence-Short Form, ICIQ-UI-SF [16]. The severity of urinary incontinence was scored based on the first three questions in the ICIQ-UI-SF, which includes the frequency of urinary incontinence, the amount of leakage, and overall inconvenience related to daily activities, with an overall score between 0 and 21. Greater values of the overall scores indicated increased severity of urinary incontinence.
The Malay versions of KAP, SESPPFE, and ICIQ-UI-SF were evaluated by a group of experts consisting of a psychologist from the UPM Faculty of Medicine and Health Sciences, a senior midwife, and a senior physiotherapist from MHKL for their appropriateness, relatedness, clarity, and presentation format. Some of the questions were fine-tuned for the questionnaire’s overall continuation, as recommended by the experts. Subsequently, the face validity of the questionnaire was tested with 10 pregnant women who attended antenatal follow-up in the outpatient obstetric clinic in MHKL. The questionnaire was well accepted by the participants and took 5 to 10 minutes to complete. Statistical analysis was undertaken in the pilot test to determine internal consistency reliability, which was acceptable for each questionnaire with Cronbach’s α ranging between 0.71 and 0.88.
At baseline, information on socio-demographic characteristics, clinical and obstetric characteristics, and health status were collected. In both study groups, data were collected at baseline immediately after recruitment and at three other points in the early third trimester (28–30 weeks of gestation), late third trimester (36–38 weeks of gestation), and early postnatal period (4–6 weeks after delivery), where the prevalence of urinary incontinence was found to be high throughout this period [2].
6. Data Analysis
Data were analyzed using IBM SPSS ver. 23.0 (IBM Corp., Armonk, NY, USA). The respondents of the study were described using descriptive statistics. Variations in baseline respondent characteristics between the intervention and control groups were analyzed using t-tests or the Mann-Whitney test for continuous variables, and chi-square tests or Fisher tests for categorical variables.
Intervention effects were analyzed with a generalized estimating equation (GEE) based on a modified intention-to-treat population that excluded respondents without follow-up measures or non-completers using a last observation carried forward imputation strategy. The GEE was used due to its flexibility, since it can accommodate unbalanced data, miss-specified correlation structure, and repeated correlated data together with unequally spaced time intervals of data collection that includes continuous and categorical outcomes [17].
For the GEE analysis, the model includes study groups, time, covariates, and group by time interaction using an autoregression working correlation with the smallest quasi-likelihood criterion adjusted for potential covariates, which was presented for each outcome. For continuous outcome measures, the link function was identified, while the logit link function was adopted for the binary outcome measure. The GEE analysis for intervention effect was illustrated as the estimated regression coefficients (β values) or differences in means for continuous outcomes, and binary outcome as the estimated odds ratios for difference in percentage with a 95% confidence interval and significance level, alpha (α) set at 0.05. A sensitivity analysis, included an intention-to-treat population with multiple imputation, complete cases that included all available data at baseline, and at all follow-ups, using GEE was carried out to determine the impact of departures from the assumption underlying the main analysis.
Ethics approval for this study was obtained from the Malaysian Ministry of Health Medical Research Ethics Committee (MREC) (NMRR-16-2029-28782) and the UPM Ethic Committee for Research involving Human Subjects (FPSK [MREC 17] P015). Written informed consent was obtained from each respondent prior to data collection. This study was retrospectively registered in the Australian New Zealand Clinical Trial Registry (ACTRN12619001733167).
The screening and recruitment processes took place between May 2017 and March 2018, with follow-ups performed until July 2018. As shown in Figure 1 (CONSORT [Consolidated Standards of Reporting Trials] diagram), a total of 1,820 subjects were screened to assess their eligibility, among which 1,561 subjects failed to meet the inclusion criteria; meanwhile, from a total of 259 pregnant women who met the inclusion criteria, 170 respondents were chosen at random and assigned to one of two study groups. Over half of the respondents, specifically 122 (71.7%), completed at least one follow-up, while 40 (23.5%) completed only one follow-up, 71 (41.7%) completed two follow-ups, and 11 (6.4%) completed all three follow-ups. There was no significant difference in the lost to follow-up rates between the intervention and control groups at any time point (P>0.05).
Table 2 displays the baseline sociodemographic and clinical characteristics of the respondents and a comparison between the intervention and control groups. The respondents were predominantly Malay, tertiary educated, working, non-smokers, multiparous, had vaginal deliveries, and constipation. Approximately one-third of the respondents had self-reported health problems. Among the 62 respondents (36.5%) who reported having urinary incontinence, 54 (31.8%) had stress urinary incontinence, and almost 17% reported pre-pregnancy urinary incontinence.
Baseline differences between the intervention and control groups were detected only for body mass index (P=0.049). However, the non-completers without any follow-up were nearly 2 years younger (P=0.046), urinary continence (P=0.022), and nulliparous (P=0.015) compared to the completers. The completers (with at least one followup) in the intervention group were more likely to be tertiary-educated (P=0.025) than the control group. Given these small differences in baseline characteristics, the randomization process was unlikely to have been compromised in this study.
Figure 2 and Table 3 display the results of the GEE model for primary and secondary outcome measures based on the modified intention-to-treat sample (n=122). The intervention group showed significant improvements relative to baseline in all primary outcomes at each time point compared to the control group. The knowledge scores from baseline in the intervention group were 6.04 (P<0.001), 5.71 (P<0.001), 6.58 (P<0.001) higher in the early third trimester, late third trimester, and early postnatal period, respectively, compared to the control group. From the late third trimester to the early postnatal period, an improvement in the knowledge score of 0.88 point (P=0.015) was observed in the intervention group. Meanwhile, in the control group, there was a small increase in knowledge score ranging between 1.25 and 1.61 points (P<0.05).
The intervention group showed an increase in the attitude score with the estimated mean difference changes compared to control groups increasing by 3.59 (P=0.002), 3.15 (P=0.006) and 3.97 (P<0.001) points from baseline to early third trimester, late third trimester and early postnatal, respectively. In addition, the attitude score increased by 0.82 points (P=0.034) from the late third trimester to early postnatal period. A similar trend was found for practice scores in the intervention group compared to those in the control group, with an increase in the estimated mean difference from baseline by 5.40 points (P<0.001) in the early third trimester, 5.93 points (P<0.001) in the late third trimester, and 6.58 points (P<0.001) in the early postnatal period. Likewise, there was a significant increase in practice score by 1.18 points (P=0.038) from early third trimester to the early postnatal period; meanwhile, there was a marginal increase in practice score (0.65 points, P=0.051) from the late third trimester to the early postnatal period. The self-efficacy scores over time in the intervention group were higher by 35.99 (P<0.001), 39.05 (P<0.001), and 41.93 (P<0.001) at the early third trimester, late third trimester, and early postnatal period, respectively, compared to the control group. In addition, an increase in the self-efficacy score was noted from the late third trimester to the early postnatal period (2.89 points, P=0.034).
In the intervention group, there was a significant reduction in the severity of urinary incontinence across all time points compared to the control group, with an estimated mean difference change ranging between 0.44 and 2.54 (P<0.001). The severity of urinary incontinence in the control group was reversed, presenting an overall increase in the severity score, which was significant in the late third trimester (1.29 points, P=0.028) and early postnatal period (1.97 points, P<0.001) compared to baseline and 1.15 points (P=0.005) from the early third trimester, respectively. The odds of self-reporting of urinary incontinence in the intervention group did not differ significantly from that in the control group over time. However, in both groups, there was an increasing trend in self-reported urinary incontinence from baseline.
The results of the sensitivity analysis based on the intention-to-treat (Table 4) and complete cases (Table 5) using GEE generally support the results of the primary analysis.
This PFME intervention has led to a significant increase in knowledge, attitude, practice, and self-efficacy, as well as a decrease in the severity of urinary incontinence among pregnant women. Specifically, the combination of educational sessions, message reminders, and one booster session in the first 8 weeks resulted in a drastic improvement in all primary outcomes at the first follow-up. After the subsequent two booster sessions, all primary outcome scores steadily increased, although not all findings met statistical significance. These results may be explained by the fact that more than half of the respondents dropped out during the booster sessions, which may have diluted the effect of the PFME intervention in the follow-up evaluation. The booster sessions, however, contributed to sustaining the initial effect and improving the primary outcomes.
The present study recorded a much higher rate of attrition, especially in the postnatal period, than was initially anticipated compared to previous studies [18-20]. This was a major challenge for the researcher to retain the respondents, while several strategies were adopted to minimize attrition. For example, to minimize the respondent’s timing burden, the intervention sessions and collection of data were scheduled based on the women’s routine antenatal and postnatal clinical visits. However, some respondents transferred to a district or health clinic for antenatal care, especially if they were classified as low risk. The possibility of transferring antenatal or postnatal care to a different location could not be ruled out prior to the recruitment process. Budgetary constraints and resource limitations made it difficult to follow up in an alternative healthcare setting. Future studies must consider a different method of data collection using an electronic-based administered questionnaire to allow pregnant women who missed their regular antenatal or postnatal clinic visits to still be able to access and participate in the study.
Nonetheless, most respondents who did not return remain unknown, particularly in the postnatal period. This indicates that attrition is also likely to occur due to other unknown barriers, including the possibility that participation may be too arduous for working women or a lack of motivation and support from healthcare professionals other than the researcher, which were not assessed in the present study [18,19]. Those who were younger, nulliparous, and did not experienced urinary incontinence were lost to follow-up in this study, indicating that they may have seen less improvement or change in symptoms; therefore, they had less interest in continuing the intervention. It is crucial to inspire this group, as they are easily demotivated and may potentially drop out from the study [19].
In this study, the finding based on a modified intention-to-treat population that excluded respondents without follow-up measures was selected as the primary analysis to ensure that the study results reflected the respondents’ experiences with the PFME intervention. Missing data were believed to be a random occurrence, since most respondents did not follow up due to transition to another healthcare setting for antenatal care, or were randomly missing, since drop-out may depend on covariates such as age, continence status, and parity. Primary analysis and complete case analysis, based on both missingness assumptions, can yield unbiased results compared to intention-to-treat with multiple imputation, particularly when the probability of being a complete case does not depend on the outcome after taking covariates into account by including covariates in the regression model [21]. Indeed, even the intention-to-treat analysis had little effect on missingness, the sensitivity test results were generally consistent with the primary analysis results. Furthermore, the direction of the effect changed in favor of the intervention group in all methods of analysis compared to the control group, suggesting that the results are sufficiently robust to account for missingness.
Overall, the present study shows positive changes in the primary outcomes, which is consistent with previous findings [22]. The higher knowledge scores observed in the intervention group, despite indicating the effectiveness of the intervention, may also be useful in distinguishing the level of detail and specific knowledge gained by the respondents in the intervention group. The small increase in knowledge scores in the control group may be explained by the fact that the control group could have been exposed to other informative sources regarding PFME via the Internet, publications and magazines, or antenatal classes [5,23,24]. This result may reflect that the control group only had cursory knowledge from other resources as compared to the intervention group that received more detailed information concerning urinary incontinence and PFME.
While most respondents in both study groups had a high positive attitude towards PFME at baseline, following PFME intervention, their attitude improved significantly, which was consistent with the outcome of a previous pre-post study [22]. In line with this result, Hill et al. [5] also revealed that pregnant women who attended antenatal education classes had a positive attitude towards urinary incontinence and PFME compared to those who did not attend. This indicates that PFME intervention offers an opportunity to shift attitudes regarding PFME, even though they had a positive attitude or mindset before the intervention.
In both groups, the PFME practice improved over time, with significant improvement observed in the intervention group compared to that in the control group. In comparison with previous studies, the present study showed that the practice of PFME increased not only in frequency, but also in terms of the collective rating of the exercise prescription, including frequency, intensity, and functional coordination [18,22,25]. In contrast, Fritel et al. [20] found that pregnant women in both the supervised prenatal PFME training group and the control group who received written information on PFME performed PFME at the same level in terms of frequency, duration, and number of repetitions. While the increased trend in practice scores in the control group could be a result of knowledge gained through usual or routine antenatal education, most of the respondents were educated and were likely to be health-conscious and practice PFME.
The results of this study showed that providing adequate information and physical skills training is a successful way to boost confidence to correctly perform PFME [11,26]. Sangsawang and Serisathien [27] supported this finding, revealing that a supervised PFME program with training skills via verbal instruction and a handbook with comprehensive PFME guidance may be an efficient method for teaching correct PFME that not only builds confidence in the ability to perform it, but also effectively improves urinary incontinence. Regarding self-efficacy, the present study highlights that effective instruction along with measured self-efficacy may help to establish a habit of exercising the pelvic floor muscles that inevitably improve exercise mastery [28].
Interestingly, in the intervention group, the severity of urinary incontinence significantly decreased over time. In the control group, the severity score was reversed and consistent with the study of Sangsawang and Serisathien [27]. The ICIQ-UI-SF scores in the intervention group decreased between 2.10 and 2.54 points over time in the highest range, and this result was comparable with the study reported by Pelaez et al. [26]. Similarly, another study revealed that the severity of urinary incontinence was significantly lower, with a mean difference of 1.99 (P<0.01) in late pregnancy following a 6-week supervised PFME intervention; however, the severity of urine incontinence was assessed using a visual analogue scale of 1–10 [29]; which could not be compared to the standard ICIQ-UI-SF minimal clinical difference of 4 points [30].
No significant difference was observed between groups in the self-reported urinary incontinence and gradually worsened, which may explain why the difference in clinical improvement in the severity of urinary incontinence was not achieved. Nonetheless, over-representation multiparous in the study sample may potentially explain the increasing risk of urinary incontinence throughout the pregnancy and the postnatal period, masking the effect of the PFME intervention. Another reason for insignificant changes in self-reported urinary incontinence could be that the sample size was inadequate to detect a difference between the groups [18,20].
The main strengths of this study include the study design (RCT) and the development of the intervention itself, which is considered quite unique, given that it was a theoretically derived intervention and was adapted to the local context together with the expert consensus. Also, the results of the present study represent real clinical data in a locally based tertiary hospital setting.
However, there are several inherent limitations. First, due to an increasing trend in attrition rate throughout the follow-up period from antenatal to postnatal, the analysis was limited to smaller samples, and imputation methods were used to maximize the data available for analysis. Although the results were similar based on primary and sensitivity analyses, the challenges associated with attrition must be addressed in future studies to increase the possibility of these programs being disseminated and resulting in clinically meaningful results, particularly related to urinary incontinence symptoms.
The second limitation was concealment, blinding, and contamination issues. While the block size was not revealed, a randomization sequence with a fixed block size could be predicted. At the same time, we could not rule out the possibility that blinding was not achieved for one or more respondents during the study, in which case those respondents may be subject to assessment bias. Steps were taken to minimize contamination; however, the possibility of contamination from information sharing could not be eliminated, especially when both study groups were recruited from a single center. Nevertheless, the respondents in the intervention groups were unlikely to be able to communicate the entire intervention program to others, since the PFME intervention consisted of components that are difficult to emulate, including education, skill, behavior change, and motivational techniques.
Another limitation is that the results of the present study may not represent the overall population of targeted pregnant women, as the respondents were only recruited from one hospital in Malaysia. Finally, limitations regarding self-reported questionnaires, especially related to practice and self-efficacy of PFME, may result in underreporting or overreporting.
In conclusion, the present study adds to the limited literature available on randomized trials that assess theory-based PFME intervention towards behavioral changes. Although the study suffered from a high lost-to-follow-up rate, the study acquired sufficient statistical power to detect the effectiveness of the PFME intervention in improving knowledge, attitude, practice, self-efficacy, and severity of urinary incontinence. Therefore, PFME is considered effective as an initial intervention in providing information about urinary incontinence prevention in pregnant women.

CONFLICT OF INTEREST

No potential conflict of interest relevant to this article was reported.

First of all, we would like to thank all the staff at the Maternity Hospital Kuala Lumpur and all the participants of this study for their support and encouragement. We are also grateful to all the members of the Faculty Medicine and Health Sciences, Universiti Putra Malaysia, especially those from the Department of Community Health, Department of Psychiatry and from the Cancer Resource and Education Center, for their continuous support throughout this study. The authors would like to thank the Director General of Health Malaysia for the permission to publish this paper.
The data that support the findings of this study are available upon request from the corresponding author. The data are not publicly available due to privacy and ethical restrictions.
Figure. 1.
CONSORT (Consolidated Standards of Reporting Trials) flow diagram of the study. FU, follow-up.
kjfm-21-0011f1.jpg
Figure. 2.
Generalized estimating equation analysis of primary and secondary outcome measures changes overtime in the intervention and control groups. (A) Estimated mean knowledge score. (B) Estimated mean attitude score. (C) Estimated mean practice score. (D) Estimated mean self-efficacy score. (E) Estimated mean sore of urinary incontinence (UI) severity. (F) Proportion of respondents reporting UI.
kjfm-21-0011f2.jpg
Table 1.
The content of pelvic floor muscle exercises intervention and delivery of the intervention
Elements of each session Purpose Information delivery
I. Single PFME education session between 18 to 21 weeks’ gestation
  Introduction To establish rapport and gain a broad understanding of respondent’s knowledge on topics to be discussed. • Therapists’ brief introduction and ice-breaking activity.
• Ask the respondent what they already know about PFME.
• Obtain the respondent’s permission to provide additional information.
Perceived susceptibility and severity To get respondent to consider that they are at risk and to raise awareness of the seriousness of the problem. • Ask participant if they think that they are at risk of developing UI and whether they are concerned that having the UI carries serious consequences.
• Provide information on UI risk link to pregnancy and childbirth and educate the respondents on the consequence or severity of the UI.
Perceived benefit of PFME To get respondents consider of the perceived efficacy of preventive measures, PFME • Ask the respondents to elaborate on the perceived benefits of PFME and discuss about the impact of not performing PFME.
Confident in performing PFME To identify perceived ability to PFME and skill deficits and also provision of practical information on PFME. • Ask the respondent if they are familiar with PFME and about their current ability to perform the exercise
• Provide practical information on PFME including instruction on how to perform the PFME correctly together with demonstrations and rehearsal with respondents
• In addition, provide tips or recommended of healthy habit during and after pregnancy.
Perceived barriers to adhere to PFME Identify challenges to PFME adherence and develop a cue to assist with adherence to exercise • Ask the respondents what is their challenges or concerns or barrier to practice and maintain PFME as recommended.
• Provide ideas and discuss in detail when respondents can do PFME within their busy life or day.
Wrap-up To give respondents an opportunity to seek further support and guidance • Allow respondents to summarize the information covered in this session by asking the participants for an explicit take away message from this session.
• Reviewing the key takeaway message
II. Text message reminder weekly for 8 weeks post-education session
Text message reminders To provide continuous support and improve adherence • Standardized message both in Malay and English.
• Message focused on PFME target, benefit of PFME and motivation cue
III. Booster sessions at the week 4 posteducation session and early thirdtrimester between 28 to 30 weeks’ gestation
Introduction To build rapport with the respondent and to create a comfortable environment for discussion • Brief introduction about the session and recap the key information shared at the previous session.
Practice of PFME To explore respondent commitments and motivation in practicing PFME. • Discussion about the commitments of practicing routine PFME.
• Provide positive reinforcement to build motivation and confidence in practicing PFME.
Wrap-up To give respondents an opportunity to raise questions and request clarifications • Summarizes and integrate all information by reviewing the respondent’s achievements, obstacles and specific strategies to overcome obstacles, maintain PFME and enhance self-efficacy.
IV. Booster session at late third-trimester between 36 to 38 weeks’ gestation
Introduction To further enhance engagement with the respondents • Brief introduction about the session.
Practice of PFME To continue exploring respondent’s ambivalence about practicing PFME • Review prior skills and practice of PFME.
• Summarize the respondent’s response and encourage continuous PFME.
Reinforce PFME after childbirth To promote and encourage respondents continuously practice PFME after childbirth • Ask participant thought of continuing PFME after childbirth.
• Provide information about the benefit of performing PFME and strategies to incorporate PFME into the daily routine of caring for a new baby during post childbirth.
• Provides tips for protecting pelvic floor muscles during the early postnatal period and reinforce the recommended healthy bladder habit.
Wrap-up To give respondents a final opportunity to seek support and guidance • Ask the participants to summarize what was covered in today’s sessions.
• Encourage and remind the participants to continue practicing PFME in daily life.

PMME, pelvic floor muscle exercise; UI, urinary incontinence.

Table 2.
Baseline characteristics of the respondents and comparison between the study groups
Characteristic Baseline comparison
 Baseline comparison among completer (n=122) (included in primary analysis)
 Baseline comparison among completer and non-completer
Intervention group (n=85) Control group (n=85) P-value Intervention group (n=63) Control group (n=59) P-value Non-completer (n=48) P-value
Age (y)* 30.3±5.1 30.9±5.3 0.429 31.0±4.6 31.3±5.5 0.782 29.4±5.5 0.046
Body mass index (kg/m2)* 25.7±5.6 27.5±6.2 0.049 26.2±5.5 27.4±6.4 0.256 26.1±5.9 0.482
Gestational (wk)* 18.8±2.2 18.8±2.0 0.912 18.7±2.2 18.9±1.8 0.434 18.7±2.3 0.870
Salary (RM)* 2,760.0±1,415.9 2,804.9±1,407.5 0.864 2,820.6±1,342.8 2,793.2±1,412.8 0.926 2,695.4±1,542.1 0.704
Ethnicity† 0.133 0.448 1.00
  Malay 75 (88.2) 67 (78.8) 55 (87.3) 46 (78.0) 41 (85.4)
Chinese 3 (3.5) 5 (5.9) 2 (3.2) 4 (6.8) 2 (4.2)
Indian 4 (4.7) 12 (14.1) 4 (6.3) 8 (13.6) 4 (8.3)
Others 3 (3.5) 1 (1.2) 2 (3.2) 1 (1.7) 1 (2.1)
Education‡ 0.093 0.025 0.463
Primary 1 (1.2) 2 (2.4) 0 2 (1.6) 1 (2.1)
Secondary 26 (30.6) 38 (44.7) 17 (27.0) 26 (44.1) 21 (43.8)
College/university 58 (68.2) 45 (52.9) 46 (73.0) 31 (52.5) 26 (54.2)
Occupational† 0.251 0.131 0.222
Public sector employed 31 (36.5) 24 (28.2) 27 (42.9) 17 (28.8) 11 (22.9)
Private sector employed 24 (28.2) 24 (28.2) 17 (27.0) 19 (32.2) 12 (25.0)
Self-employed 5 (5.9) 3 (3.5) 4 (6.3) 1 (1.7) 3 (6.3)
Housewife 23 (27.1) 34 (40.0) 14 (22.2) 22 (37.3) 21 (43.8)
Others 2 (2.4) - 1 (1.6) 0 1 (0.6)
Parity‡ 0.752 0.701 0.022
Nulliparous 33 (38.8) 31 (36.5) 19 (30.2) 20 (33.9) 25 (52.1)
Multiparous ≥1 52 (61.2) 54 (63.5) 44 (69.8) 39 (66.1) 23 (47.9)
History of delivery‡ 0.612 0.938 0.065
SVD 35 (41.2) 39 (45.9) 31 (49.2) 29 (49.2) 14 (29.2)
LSCS 9 (10.6) 11 (12.9) 8 (12.7) 7 (11.9) 5 (10.4)
Both SVD & LSCS 8 (9.4) 4 (4.7) 5 (7.9) 3 (5.1) 4 (8.3)
Nil 33 (38.8) 31 (36.5) 19 (32.0) 20 (33.9) 25 (52.1)
Pre-pregnancy UI‡ 0.679 0.649 0.251
Yes 15 (17.6) 13 (15.3) 13 (20.6) 10 (16.9) 5 (10.4)
No 70 (82.4) 72 (84.7) 50 (79.4) 49 (83.1) 43 (89.6)
History of smoking† 0.682 0.366 0.322
Yes 4 (4.7) 2 (2.4) 4 (6.3) 1 (1.7) 1 (2.1)
No 81 (95.3) 82 (96.5) 59 (93.7) 58 (98.3) 46 (95.8)
Currently smoking - 1 (1.2) 0 0 1 (2.1)
Health history†
Nil 59 (69.4) 57 (67.1) 0.990 43 (68.3) 41 (69.5) 0.856 32 (66.7) 0.950
UTI 3× per year 2 (2.4) 3 (3.5) 2 (3.2) 2 (3.4) 1 (2.1)
Heart problem 2 (2.4) 3 (3.5) 1 (1.6) 2 (3.4) 2 (4.2)
Asthma 7 (8.2) 8 (9.4) 4 (6.3) 6 (10.2) 5 (10.4)
Depression 1 (1.2) - 1 (1.6) 0 -
Others 14 (16.5) 14 (16.5) 12 (19.0) 8 (13.6) 8 (16.7)
Constipation‡ 0.153 0.233 0.827
Never 27 (31.8) 34 (40.0) 20 (31.7) 25 (42.4) 16 (33.3)
Seldom (less than 1× monthly) 31 (36.5) 27 (31.8) 23 (36.5) 19 (32.2) 16 (33.3)
Sometimes (less than 2× weekly) 17 (20.0) 21 (24.7) 12 (19.0) 13 (22.0) 13 (27.1)
Often (at least 3× weekly) 10 (11.8) 3 (3.5) 8 (12.7) 2 (3.4) 3 (6.3)
Type of UI† 0.486 0.660 0.064
Nil 50 (58.8) 58 (68.2) 34 (54.0) 37 (62.7) 37 (77.1)
SUI 30 (35.3) 24 (28.2) 25 (39.7) 19 (32.2) 10 (20.8)
UUI 5 (5.9) 3 (3.5) 4 (6.3) 3 (5.1) 1 (2.1)
Continence status‡ 0.200 0.328 0.022
Continence 50 (58.8) 58 (68.2) 34 (54.0) 37 (62.7) 37 (77.1)
Incontinence 35 (41.2) 27 (31.8) 29 (46.0) 22 (37.3) 11 (22.9)

Values are presented as mean±standard deviation or number of respondents (%). P-value significant at P<0.05.

SVD, spontaneous vaginal delivery; LSCS, lower segment cesarean section; UI, urinary incontinence; SUI, stress urinary incontinence; UTI, urinary tract infection; UUI, urge urinary incontinence.

*By t-test.

†By Fisher’s exact test.

‡By chi-square test.

Table 3.
Generalized estimating equations models parameter for pelvic floor muscle exercise intervention effect on primary and secondary outcome measures among completer
Outcome measure and timepoints IG (n=63) CG (n=59) Difference or OR between group (95% CI) P-value
Knowledge
  Baseline* 7.27±1.57 7.07±1.62 0.20 (-0.95 to 1.35) 1.000
Early third trimester change from baseline† -7.29±0.76 -1.25±0.62 6.04 (4.11 to 7.96) <0.001
Late third trimester change from baseline† -7.32±0.75 -1.61±0.65 5.71 (3.77 to 7.65) <0.001
Early postnatal change from baseline† -8.14±0.69 -1.56±0.64 6.58 (4.74 to 8.43) <0.001
Late third trimester change from early third trimester† -0.03±0.16 -0.36±0.27 -0.32 (-0.93 to 0.28) 0.295
Early postnatal change from early third trimester† -0.86±0.38 -0.31±0.29 0.55 (-0.39 to1.49) 0.249
Early postnatal change from late third trimester† -0.83±0.34 0.05±0.12 0.88 (0.17 to 1.58) 0.015
Attitude
Baseline* 30.73±8.83 30.45±8.87 0.28 (-0.54 to 1.10) 1.000
Early third trimester change from baseline† -3.02±0.91 0.58±0.67 3.60 (1.37 to 5.82) 0.002
Late third trimester change from baseline† -2.56±0.97 0.59±0.59 3.15 (0.92 to 5.3) 0.006
Early postnatal change from baseline† -3.43±0.94 0.54±0.61 3.97 (1.78 to 6.16) <0.001
Late third trimester change from early third trimester† 0.46±0.55 0.02±0.42 -0.44 (-1.81 to 0.92) 0.524
Early postnatal change from early third trimester† -0.41±0.66 -0.03±0.46 0.38 (-1.21 to 1.96) 0.639
Early postnatal change from late third trimester† -0.87±0.36 -0.05±0.14 0.82 (0.06 to 1.58) 0.034
Practice
Baseline* 9.07±2.05 8.62±2.23 0.45 (-0.54 t0 1.46) 1.000
Early third trimester change from baseline† -6.40±0.74 -1.00±0.50 5.40 (3.65 to 7.15) <0.001
Late third trimester change from baseline† -7.35±0.78 -1.42±0.53 5.93 (4.08 to 7.78) <0.001
Early postnatal change from baseline† -7.97±0.74 -1.39±0.52 6.58 (4.82 to 8.34) <0.001
Late third trimester change from early third trimester† -0.95±0.43 -0.42±0.23 0.53 (-0.43 to -0.49) 0.279
Early postnatal change from early third trimester† -1.57±0.51 -0.39±0.25 1.18 (0.07 to 2.30) 0.038
Early postnatal change from late third trimester† -0.62±0.33 0.03±0.08 0.65 (0.00 to 1.31) 0.051
Self-efficacy
Baseline* 36.50±4.75 34.18±4.99 2.33 (-13.59 to 18.25) 1.000
Early third trimester change from baseline† -34.53±3.53 1.46±2.86 35.99 (27.08 to 44.90) <0.001
Late third trimester change from baseline† -38.51±3.48 0.54±3.16 39.05 (29.83 to 48.26) <0.001
Early postnatal change from baseline† -40.02±3.25 1.91±3.26 41.93 (32.91 to 50.96) <0.001
Late third trimester change from early third trimester† -3.97±2.18 -0.92±1.88 3.06 (-2.59 to 8.70) 0.289
Early postnatal change from early third trimester† -5.49±2.40 0.46±2.03 5.94 (-0.22 to 12.11) 0.059
Early postnatal change from late third trimester† -1.51±1.12 1.38±0.77 2.89 (0.22 to 5.55) 0.034
Severity of urinary incontinence
Baseline* 2.97±0.67 2.79±0.72 0.18 (-0.38 to 0.74) 1.000
Early third trimester change from baseline† 0.30±0.31 -0.81±0.37 -1.12 (-2.07 to -0.16) 0.022
Late third trimester change from baseline† 0.81±0.34 -1.29±0.39 -2.10 (-3.11 to -1.09) <0.001
Early postnatal change from baseline† 0.57±0.36 -1.97±0.45 -2.54 (-3.67 to -1.41) <0.001
Late third trimester change from early third trimester† 0.51±0.16 -0.47±0.21 -0.98 (-1.50 to 0.47) <0.001
Early postnatal change from early third trimester† 0.27±0.24 -1.15±0.31 -1.42 (-2.19 to -0.66) <0.001
Early postnatal change from late third trimester† -0.24±0.18 -0.68±0.25 -0.44 (-1.04 to 0.16) <0.001
Self-reported urinary incontinence
Baseline‡ 39.7 (25) 33.9 (20) 0.508
Early third trimester change from baseline§ 7.9 (5) 13.6 (8) 0.83 (0.48 to 1.43) 0.499
Late third trimester change from baseline§ 14.3 (9) 16.9 (10) 0.63 (0.33 to 1.18) 0.149
Early postnatal change from baseline§ 22.2 (14) 27.1 (16) 0.601 (0.29 to 1.24) 0.170
Late third trimester change from early third trimester§ 6.4 (4) 3.3 (2) 0.76 (0.55 to 1.05) 0.099
Early postnatal change from early third trimester§ 14.3 (9) 13.5 (8) 0.725 (0.44 to 1.19) 0.206
Early postnatal change from late third trimester§ 7.9 (5) 10.2 (6) 0.961 (0.66 to 1.40) 0.834

Values are presented as estimated mean±standard error or % (number of respondents). P-value significant P<0.05.

IG, intervention group; CG, control group; OR, odds ratio; CI, confidence interval.

*The estimates mean difference at baseline and

†the changes over time between group (expressed as Exp [β] or exponentiation of the beta coefficient) based on generalized estimating equation model: time, group, and group by time interaction adjusted for baseline value and covariates.

‡Percentage difference present between study groups at baseline was calculated using the chi-square test.

§Percentage changes over time between group expressed as OR based on generalized estimating equation model: time, group, covariate, and group by time interaction. Percentage change in number of respondents between two timepoints: a positive value is an increase; a negative value is a decrease.

Table 4.
Generalized estimating equations models parameter for pelvic floor muscle exercise intervention effect on primary and secondary outcome measures based on intention-to-treat with multiple imputation
Outcome measure and timepoints IG (n=85) CG (n=85) Difference or OR between group (95% CI) P-value
Knowledge
  Baseline* 6.78±0.93 6.52±0.96 -0.26 (-1.19 to 0.68) 0.590
Early third trimester change from baseline† -7.27±0.60 -2.96±0.55 4.31 (2.72 to 5.90) <0.001
Late third trimester change from baseline† -7.56±0.61 -3.38±0.58 4.18 (2.53 to 5.83) <0.001
Early postnatal change from baseline† -6.39±0.67 -5.80±0.68 0.60 (-1.27 to 2.46) 0.530
Late third trimester change from early third trimester† -0.30±0.16 -0.43±0.23 -0.13 (-0.67 to 0.41) 0.641
Early postnatal change from early third trimester† 0.87±0.43 -2.84±0.66 -3.71 (-5.26 to -2.17) <0.001
Early postnatal change from late third trimester† 1.17±0.43 -2.41±0.66 -3.58 (-5.14 to -2.03) <0.001
Attitude
Baseline* 30.36±4.75 30.12±4.75 -0.24 (-1.04 to 0.56) 0.559
Early third trimester change from baseline† -2.88±0.76 -0.14±0.58 2.74 (0.87 to 4.62) 0.004
Late third trimester change from baseline† -2.52±0.80 -0.15±0.55 2.37 (0.48 to 4.27) 0.014
Early postnatal change from baseline† -3.71±0.57 -3.40±0.56 0.31 (-1.26 to 1.88) 0.701
Late third trimester change from early third trimester† 0.36±0.52 -0.01±0.39 -0.37 (-1.64 to -0.91) 0.570
Early postnatal change from early third trimester† -0.82±0.67 -3.26±0.63 -2.44 (-4.24 to 0.64) 0.008
Early postnatal change from late third trimester† -1.18±0.73 -3.25±0.62 -2.07 (-3.93 to -0.20) 0.030
Practice
Baseline* 8.73±1.16 8.33±1.26 -0.40 (-1.09 to 0.28) 0.249
Early third trimester change from baseline† -6.48±0.56 -1.83±0.46 4.65 (3.24 to 6.07) <0.001
Late third trimester change from baseline† -7.46±0.61 -2.22±0.52 5.24 (3.68 to 6.81) <0.001
Early postnatal change from baseline† -5.20±0.55 -5.13±0.51 0.07 (-1.41 to 1.55) 0.928
Late third trimester change from early third trimester† -0.98±0.33 -0.39±0.27 0.59 (-2.24 to 1.43) 0.164
Early postnatal change from early third trimester† 1.28±0.48 -3.30±0.49 -4.58 (-5.93 to -3.24) <0.001
Early postnatal change from late third trimester† 2.26±0.56 -2.91±0.62 -5.18 (-6.81 to -3.68) <0.001
Self-efficacy
Baseline* 34.00±3.81 32.79±3.77 -1.22 (-10.14 to 7.71) 0.789
Early third trimester change from baseline† -34.43±3.06 -5.83±2.91 28.60 (20.32 to 36.88) <0.001
Late third trimester change from baseline† -38.91±3.11 -6.69±3.21 32.22 (23.46 to 40.99) <0.001
Early postnatal change from baseline† -18.19±3.29 12.98±3.27 5.22 (-3.87 to 14.31) 0.260
Late third trimester change from early third trimester† -4.49±1.55 -0.86±1.59 3.62 (-0.73 to 7.98) 0.103
Early postnatal change from early third trimester† 16.23±2.09 -7.15±2.84 -23.38 (-30.29 to 16.47) <0.001
Early postnatal change from late third trimester† 20.72±2.34 -6.29±2.86 -27.00 (-34.24 to -19.77) <0.001
Severity of urinary incontinence
Baseline* 2.73±0.54 2.39±0.55 -0.34 (-0.92 to 0.23) 0.238
Early third trimester change from baseline† -0.13±0.28 -0.99±0.35 -0.86 (-1.74 to 0.02) 0.054
Late third trimester change from baseline† 0.17±0.35 -1.50±0.37 -1.67 (-2.66 to -0.68) 0.001
Early postnatal change from baseline† -2.00±0.43 -3.04±0.42 -1.04 (-2.21 to 0.14) 0.084
Late third trimester change from early third trimester† 0.30±0.17 -0.51±0.20 -0.81 (-1.33 to -0.29) 0.002
Early postnatal change from early third trimester† -1.87±0.32 -2.05±0.38 -0.17 (-1.14 to 0.79) 0.724
Early postnatal change from late third trimester† -2.18±0.27 -1.54±0.37 0.64 (-0.25 to 1.52) 0.160
Self-reported urinary incontinence
Baseline‡ 41.2 (35) 31.8 (27) - 0.202
Early third trimester change from baseline§ 12.9 (11) 17.6 (15) 0.78 (0.37 to 1.69) 0.535
Late third trimester change from baseline§ 15.3 (13) 21.2 (18) 0.77 (0.29 to 2.07) 0.604
Early postnatal change from baseline§ 15.3 (13) 10.6 (9) 1.26 (0.45 to 3.55) 0.659
Late third trimester change from early third trimester§ 2.4 (2) 3.5 (3) 0.95 (0.45 to 2.02) 0.898
Early postnatal change from early third trimester§ 2.4 (2) 7.1 (-6) 1.59 (0.55 to 4.60) 0.392
Early postnatal change from late third trimester§ 0 10.6 (-9) 1.68 (0.65 to 4.39) 0.286

Values are presented as estimated mean±standard error or % (number of respondents). P-value significant P<0.05.

IG, intervention group; CG, control group; OR, odd ratio; CI, confidence interval.

*The estimates mean difference at baseline and

†the changes over time between group (expressed as Exp [β] or exponentiation of the beta coefficient) based on generalized estimating equation model: time, group, and group by time interaction adjusted for baseline value and covariates.

‡Percentage difference present between study groups at baseline was calculated using the chi-square test.

§Percentage changes over time between group expressed as OR based on generalized estimating equation model: time, group, covariate, and group by time interaction. Percentage change in number of respondents between two timepoints: a positive value is an increase; a negative value is a decrease.

Table 5.
Generalized estimating equations models parameter for pelvic floor muscle exercise intervention effect on primary and secondary outcome measures based on complete cases or all available data from baseline to end of follow-up without imputation
Outcome measure and timepoints IG CG Parameters Estimated mean difference or OR between groups (95% CI) P-value
Knowledge
  Baseline* (n=170, IG:85, CG:85) 6.96±1.23 6.88±1.25 Early third trimester change from baseline† 6.48 (4.53 to 8.43) <0.001
Early third trimester* (n=112, IG: 58, CG:54) 14.85±1.30 8.29±1.29 Late third trimester change from baseline† 5.78 (3.72 to 7.83) <0.001
Late third trimester* (n=82, IG:42, CG:40) 14.65±1.31 8.78±1.29 Early postnatal change from baseline† 9.02 (6.99 to 11.05) <0.001
Early postnatal* (n=21, IG:10, CG:11) 17.18±1.23 8.07±1.29 Late third trimester change from early third trimester† -0.88 (-2.09 to 0.34) 0.156
Early postnatal change from early third trimester† 1.72 (-1.30 to 4.75) 0.264
Early postnatal change from late third trimester† 2.52 (-0.65 to 5.69) 0.119
Attitude
Baseline* (n=170, IG:85, CG:85) 30.48±6.49 30.41±6.50 Early third trimester change from baseline† 3.92 (1.53 to 6.30) 0.001
Early third trimester* (n=112, IG: 58, CG:54) 33.85±6.46 29.85±6.50 Late third trimester change from baseline† 2.65 (0.06 to 5.24) 0.045
Late third trimester* (n=82, IG:42, CG:40) 32.56±6.40 29.84±6.53 Early postnatal change from baseline† 6.59 (3.81 to 9.38) <0.001
Early postnatal* (n=21, IG:10, CG:11) 37.28±6.38 30.61±6.55 Late third trimester change from early third trimester† -2.10 (-4.24 to 0.03) 0.054
Early postnatal change from early third trimester† 1.21 (-2.32 to 4.73) 0.503
Early postnatal change from late third trimester† 3.27 (-0.41 to 6.95) 0.082
Practice
Baseline* (n=170, IG:85, CG:85) 8.82±1.74 8.64±1.81 Early third trimester change from baseline† 5.96 (4.18 to 7.73) <0.001
Early third trimester* (n=112, IG: 58, CG:54) 15.85±1.86 9.71±1.77 Late third trimester change from baseline† 6.56 (4.49 to 8.64) <0.001
Late third trimester* (n=82, IG:42, CG:40) 16.91±1.95 10.17±1.83 Early postnatal change from baseline† 8.10 (5.83 to 10.38) <0.001
Early postnatal* (n=21, IG:10, CG:11) 17.76±2.07 9.48±1.82 Late third trimester change from early third trimester† 0.43 (-1.10 to -1.97) 0.579
Early postnatal change from early third trimester† 2.38 (-0.58 to 5.34) 0.115
Early postnatal change from late third trimester† 1.96 (-1.31 to 5.23) 0.239
Self-efficacy
Baseline* (n=170, IG:85, CG:85) 34.07±4.51 32.93±4.36 Early third trimester change from baseline† 45.86 (35.82 to 55.90) <0.001
Early third trimester* (n=112, IG: 58, CG:54) 73.08±3.32 32.55±4.53 Late third trimester change from baseline† 46.66 (34.86 to 58.47) <0.001
Late third trimester* (n=82, IG:42, CG:40) 79.38±3.84 32.38±4.79 Early postnatal change from baseline† 4.89 (-2.35 to 12.12) <0.001
Early postnatal* (n=21, IG:10, CG:11) 73.47±4.24 25.67±5.45 Late third trimester change from early third trimester† 39.39 (30.64 to 48.12) 0.189
Early postnatal change from early third trimester† 7.17 (-3.90 to 18.23) 0.204
Early postnatal change from late third trimester† 6.38 (-6.47 to 19.23) 0.330
Severity of urinary incontinence
Baseline* (n=170, IG:85, CG:85) 2.83±0.60 2.69±0.62 Early third trimester change from baseline† -1.16 (-2.07 to -0.15) 0.024
Early third trimester* (n=112, IG: 58, CG:54) 2.56±0.62 3.59±0.73 Late third trimester change from baseline† -2.40 (-3.58 to -1.23) <0.001
Late third trimester* (n=82, IG:42, CG:40) 1.98±0.66 4.25±0.72 Early postnatal change from baseline† -3.81 (-6.36 to -1.26) 0.003
Early postnatal* (n=21, IG:10, CG:11) 3.57±1.10 7.24±1.10 Late third trimester change from early third trimester† -1.28 (-2.15 to -0.41) 0.004
Early postnatal change from early third trimester† -2.14 (-4.88 to -0.60) 0.126
Early postnatal change from late third trimester† -0.89 (-3.69 to 1.91) 0.532
Self-reported urinary incontinence
Baseline‡ (n=170, IG:85, CG:85) 41.2 (35) 31.8 (27) Early third trimester change from baseline§ 0.81 (0.46 to 1.44) 0.481
Early third trimester‡ (n=112, IG: 58, CG:54) 55.2 (32) 48.1 (26) Late third trimester change from baseline§ 0.54 (0.26 to 1.10) 0.090
Late third trimester‡ (n=82, IG:42, CG:40) 52.4 (22) 57.5 (23) Early postnatal change from baseline§ 0.54 (0.07 to 4.13) 0.555
Early postnatal‡ (n=21, IG:10, CG:11) 70 (7) 81.8 (9) Late third trimester change from early third trimester§ 0.74 (0.42 to 1.30) 0.297
Early postnatal change from early third trimester§ 0.67 (0.10 to 4.48) 0.679
Early postnatal change from late third trimester§ 1.04 (0.13 to 8.53) 0.973

Values are presented as estimated mean±standard error or % (number of respondents). P-value significant P<0.05.

IG, intervention group; CG, control group; OR, odd ratio; CI, confidence interval.

*The estimated mean and standard error at each timepoint in the intervention and control group and

†the changes over time between group (expressed as Exp [β] or exponentiation of the beta coefficient) based on generalized estimating equation model: time, group, and group by time interaction adjusted for baseline value and covariates.

‡Percentage (number of respondents) present at each timepoint was calculated using descriptive analysis.

§Percentage changes over time between group expressed as OR based on generalized estimating equation model: time, group, covariate, and group by time interaction.

  • 1. Lukacz ES, Sampselle C, Gray M, Macdiarmid S, Rosenberg M, Ellsworth P, et al. A healthy bladder: a consensus statement. Int J Clin Pract 2011;65:1026-36.
  • 2. Fritel X, Ringa V, Quiboeuf E, Fauconnier A. Female urinary incontinence, from pregnancy to menopause: a review of epidemiological and pathophysiological findings. Acta Obstet Gynecol Scand 2012;91:901-10.
  • 3. Abdullah B, Ayub SH, Mohd Zahid AZ, Noorneza AR, Isa MR, Ng PY. Urinary incontinence in primigravida: the neglected pregnancy predicament. Eur J Obstet Gynecol Reprod Biol 2016;198:110-5.
  • 4. Mohd Yusoff D, Awang S, Kueh YC. Urinary incontinence among pregnant women attending an antenatal clinic at a tertiary teaching hospital in North-East Malaysia. J Taibah Univ Med Sci 2018;14:39-46.
  • 5. Hill AM, McPhail SM, Wilson JM, Berlach RG. Pregnant women’s awareness, knowledge and beliefs about pelvic floor muscles: a cross-sectional survey. Int Urogynecol J 2017;28:1557-65.
  • 6. Liu J, Tan SQ, Han HC. Knowledge of pelvic floor disorder in pregnancy. Int Urogynecol J 2019;30:991-1001.
  • 7. Rosediani M, NH NR, Juliawati M, Norwati D. Knowledge, attitude and practice towards pelvic floor muscle exercise among pregnant women attending antenatal clinic in Universiti Sains Malaysia Hospital, Malaysia. Int Med J 2012;19:37-8.
  • 8. Boyle R, Hay-Smith EJ, Cody JD, Mørkved S. Pelvic floor muscle training for prevention and treatment of urinary and faecal incontinence in antenatal and postnatal women. Cochrane Database Syst Rev 2012;10:CD007471.
  • 9. Morkved S, Bo K. Effect of pelvic floor muscle training during pregnancy and after childbirth on prevention and treatment of urinary incontinence: a systematic review. Br J Sports Med 2014;48:299-310.
  • 10. Woodley SJ, Boyle R, Cody JD, Morkved S, Hay-Smith EJ. Pelvic floor muscle training for prevention and treatment of urinary and faecal incontinence in antenatal and postnatal women. Cochrane Database Syst Rev 2017;12:CD007471.
  • 11. Hay-Smith J, Dean S, Burgio K, McClurg D, Frawley H, Dumoulin C. Pelvic-floor-muscle-training adherence “modifiers”: a review of primary qualitative studies: 2011 ICS State-of-the-Science Seminar research paper III of IV. Neurourol Urodyn 2015;34:622-31.
  • 12. McClurg D, Frawley H, Hay-Smith J, Dean S, Chen SY, Chiarelli P, et al. Scoping review of adherence promotion theories in pelvic floor muscle training: 2011 ICS State-of-the-Science Seminar research paper I of IV. Neurourol Urodyn 2015;34:606-14.
  • 13. Chow SC, Shao J, Wang H. Sample size calculations in clinical research. 2nd ed. Boca Raton (FL): Chapman & Hall/CRC; 2008.
  • 14. Miller WR, Rollnick S. Motivational interviewing: helping people change. 3rd ed. New York (NY): Guilford Press; 2013.
  • 15. Sacomori C, Cardoso FL, Porto IP, Negri NB. The development and psychometric evaluation of a self-efficacy scale for practicing pelvic floor exercises. Braz J Phys Ther 2013;17:336-42.
  • 16. Lim R, Liong ML, Lau YK, Yuen KH. Validity, reliability, and responsiveness of the ICIQ-UI SF and ICIQ-LUTSqol in the Malaysian population. Neurourol Urodyn 2017;36:438-42.
  • 17. Wang M, Kong L, Li Z, Zhang L. Covariance estimators for generalized estimating equations (GEE) in longitudinal analysis with small samples. Stat Med 2016;35:1706-21.
  • 18. Mason L, Roe B, Wong H, Davies J, Bamber J. The role of antenatal pelvic floor muscle exercises in prevention of postpartum stress incontinence: a randomised controlled trial. J Clin Nurs 2010;19:2777-86.
  • 19. Kocaoz S, Eroglu K, Sivaslioglu AA. Role of pelvic floor muscle exercises in the prevention of stress urinary incontinence during pregnancy and the postpartum period. Gynecol Obstet Invest 2013;75:34-40.
  • 20. Fritel X, de Tayrac R, Bader G, Savary D, Gueye A, Deffieux X, et al. Preventing urinary incontinence with supervised prenatal pelvic floor exercises: a randomized controlled trial. Obstet Gynecol 2015;126:370-7.
  • 21. Hughes RA, Heron J, Sterne JAC, Tilling K. Accounting for missing data in statistical analyses: multiple imputation is not always the answer. Int J Epidemiol 2019;48:1294-304.
  • 22. Muhammad J, Muhamad R, Husain NR, Daud N. Pelvic floor muscle exercise education and factors associated with implementation among antenatal women in Hospital Universiti Sains Malaysia. Korean J Fam Med 2019;40:45-52.
  • 23. O’Neill AT, Hockey J, O’Brien P, Williams A, Morris TP, Khan T, et al. Knowledge of pelvic floor problems: a study of third trimester, primiparous women. Int Urogynecol J 2017;28:125-9.
  • 24. Daly D, Cusack C, Begley C. Learning about pelvic floor muscle exercises before and during pregnancy: a cross-sectional study. Int Urogynecol J 2019;30:965-75.
  • 25. Stafne SN, Salvesen KA, Romundstad PR, Torjusen IH, Morkved S. Does regular exercise including pelvic floor muscle training prevent urinary and anal incontinence during pregnancy?: a randomised controlled trial. BJOG 2012;119:1270-80.
  • 26. Pelaez M, Gonzalez-Cerron S, Montejo R, Barakat R. Pelvic floor muscle training included in a pregnancy exercise program is effective in primary prevention of urinary incontinence: a randomized controlled trial. Neurourol Urodyn 2014;33:67-71.
  • 27. Sangsawang B, Serisathien Y. Effect of pelvic floor muscle exercise programme on stress urinary incontinence among pregnant women. J Adv Nurs 2012;68:1997-2007.
  • 28. Whitford HM, Jones M. An exploration of the motivation of pregnant women to perform pelvic floor exercises using the revised theory of planned behaviour. Br J Health Psychol 2011;16:761-78.
  • 29. Sangsawang B, Sangsawang N. Is a 6-week supervised pelvic floor muscle exercise program effective in preventing stress urinary incontinence in late pregnancy in primigravid women?: a randomized controlled trial. Eur J Obstet Gynecol Reprod Biol 2016;197:103-10.
  • 30. Lim R, Liong ML, Lim KK, Leong WS, Yuen KH. The minimum clinically important difference of the International Consultation on Incontinence Questionnaires (ICIQ-UI SF and ICIQ-LUTSqol). Urology 2019;133:91-5.

Figure & Data

References

    Citations

    Citations to this article as recorded by  
    • Prenatal Exercise Decreases Urinary Incontinence in Late Pregnancy and 3 Months Postpartum: A Randomized Controlled Trial
      DINGFENG ZHANG, MIGUEL SÁNCHEZ-POLÁN, CRISTINA SILVA-JOSE, ÁNGELES DÍAZ-BLANCO, MAIA BRIK, ARANZAZU MARTÍN ARIAS, PALOMA HERNANDO, RUBÉN BARAKAT
      Medicine & Science in Sports & Exercise.2025; 57(3): 555.     CrossRef
    • Effect of lattice CO2 laser combined with Kegel exercise mild moderate stress urinary incontinence and postpartum depression anxiety
      Zhao-Xia Lou, Shu-Ying Huang, Ze-Qiu Wan, Yun Chen, Hua-Ying Shan, Ling-Yan Wang
      World Journal of Psychiatry.2025;[Epub]     CrossRef
    • Compliance and Adherence to Pelvic Floor Exercise Therapy in People with Pelvic Floor Disorders: A Systematic Review and Meta-Analysis
      Inmaculada Villa-Del-Pino, José-Jesús Jiménez-Rejano, Manuel Rebollo-Salas, Álvaro-José Rodríguez-Domínguez, Carmen-María Suárez-Serrano
      Life.2025; 15(4): 613.     CrossRef
    • Influence of pelvic floor muscle training alone or as part of a general physical activity program during pregnancy on urinary incontinence, episiotomy and third‐ or fourth‐degree perineal tear: Systematic review and meta‐analysis of randomized clinical tr
      Dingfeng Zhang, Kari Bo, Rocío Montejo, Miguel Sánchez‐Polán, Cristina Silva‐José, Montse Palacio, Rubén Barakat
      Acta Obstetricia et Gynecologica Scandinavica.2024; 103(6): 1015.     CrossRef
    • Knowledge, attitudes, and practices of pelvic floor muscle exercises among pregnant women visiting public hospitals
      Javeria Saeed, Laiba Abdullah
      Journal of Basic & Clinical Medical Sciences.2023; 1: 12.     CrossRef
    • Preliminary Findings on Urinary Incontinence Screening Among Childbearing Women Attending Maternal and Child Health Clinic in Kuantan
      Siti Mariam Muda, Umi Maisarah Sutaji, Muzaitul Akma Mustapa Kamal Basha, Haliza Hasan, Zalina Nusee
      Malaysian Journal of Medicine and Health Sciences.2022; 18(s19): 142.     CrossRef
    • Effects of exercises for strengthening pelvic floor muscles in pregnant women
      Ranka Ogurlić, Anka Vukićević, Ljiljana Stijepović
      Medicinski casopis.2022; 56(4): 107.     CrossRef

    Download Citation

    Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

    Format:

    Include:

    Effectiveness of a Pelvic Floor Muscle Exercise Intervention in Improving Knowledge, Attitude, Practice, and Self-Efficacy among Pregnant Women: A Randomized Controlled Trial
    Korean J Fam Med. 2022;43(1):42-55.   Published online January 20, 2022
    DOI: https://doi.org/10.4082/kjfm.21.0011
    Download Citation
    Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.
    Format:
    • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
    • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
    Include:
    • Citation for the content below
    Effectiveness of a Pelvic Floor Muscle Exercise Intervention in Improving Knowledge, Attitude, Practice, and Self-Efficacy among Pregnant Women: A Randomized Controlled Trial
    Korean J Fam Med. 2022;43(1):42-55.   Published online January 20, 2022
    DOI: https://doi.org/10.4082/kjfm.21.0011
    Close

    Figure

    • 0
    • 1
    Effectiveness of a Pelvic Floor Muscle Exercise Intervention in Improving Knowledge, Attitude, Practice, and Self-Efficacy among Pregnant Women: A Randomized Controlled Trial
    Image Image
    Figure. 1. CONSORT (Consolidated Standards of Reporting Trials) flow diagram of the study. FU, follow-up.
    Figure. 2. Generalized estimating equation analysis of primary and secondary outcome measures changes overtime in the intervention and control groups. (A) Estimated mean knowledge score. (B) Estimated mean attitude score. (C) Estimated mean practice score. (D) Estimated mean self-efficacy score. (E) Estimated mean sore of urinary incontinence (UI) severity. (F) Proportion of respondents reporting UI.

    Figure. 1.

    Figure. 2.

    Effectiveness of a Pelvic Floor Muscle Exercise Intervention in Improving Knowledge, Attitude, Practice, and Self-Efficacy among Pregnant Women: A Randomized Controlled Trial
    Elements of each session Purpose Information delivery
    I. Single PFME education session between 18 to 21 weeks’ gestation
      Introduction To establish rapport and gain a broad understanding of respondent’s knowledge on topics to be discussed. • Therapists’ brief introduction and ice-breaking activity.
    • Ask the respondent what they already know about PFME.
    • Obtain the respondent’s permission to provide additional information.
    Perceived susceptibility and severity To get respondent to consider that they are at risk and to raise awareness of the seriousness of the problem. • Ask participant if they think that they are at risk of developing UI and whether they are concerned that having the UI carries serious consequences.
    • Provide information on UI risk link to pregnancy and childbirth and educate the respondents on the consequence or severity of the UI.
    Perceived benefit of PFME To get respondents consider of the perceived efficacy of preventive measures, PFME • Ask the respondents to elaborate on the perceived benefits of PFME and discuss about the impact of not performing PFME.
    Confident in performing PFME To identify perceived ability to PFME and skill deficits and also provision of practical information on PFME. • Ask the respondent if they are familiar with PFME and about their current ability to perform the exercise
    • Provide practical information on PFME including instruction on how to perform the PFME correctly together with demonstrations and rehearsal with respondents
    • In addition, provide tips or recommended of healthy habit during and after pregnancy.
    Perceived barriers to adhere to PFME Identify challenges to PFME adherence and develop a cue to assist with adherence to exercise • Ask the respondents what is their challenges or concerns or barrier to practice and maintain PFME as recommended.
    • Provide ideas and discuss in detail when respondents can do PFME within their busy life or day.
    Wrap-up To give respondents an opportunity to seek further support and guidance • Allow respondents to summarize the information covered in this session by asking the participants for an explicit take away message from this session.
    • Reviewing the key takeaway message
    II. Text message reminder weekly for 8 weeks post-education session
    Text message reminders To provide continuous support and improve adherence • Standardized message both in Malay and English.
    • Message focused on PFME target, benefit of PFME and motivation cue
    III. Booster sessions at the week 4 posteducation session and early thirdtrimester between 28 to 30 weeks’ gestation
    Introduction To build rapport with the respondent and to create a comfortable environment for discussion • Brief introduction about the session and recap the key information shared at the previous session.
    Practice of PFME To explore respondent commitments and motivation in practicing PFME. • Discussion about the commitments of practicing routine PFME.
    • Provide positive reinforcement to build motivation and confidence in practicing PFME.
    Wrap-up To give respondents an opportunity to raise questions and request clarifications • Summarizes and integrate all information by reviewing the respondent’s achievements, obstacles and specific strategies to overcome obstacles, maintain PFME and enhance self-efficacy.
    IV. Booster session at late third-trimester between 36 to 38 weeks’ gestation
    Introduction To further enhance engagement with the respondents • Brief introduction about the session.
    Practice of PFME To continue exploring respondent’s ambivalence about practicing PFME • Review prior skills and practice of PFME.
    • Summarize the respondent’s response and encourage continuous PFME.
    Reinforce PFME after childbirth To promote and encourage respondents continuously practice PFME after childbirth • Ask participant thought of continuing PFME after childbirth.
    • Provide information about the benefit of performing PFME and strategies to incorporate PFME into the daily routine of caring for a new baby during post childbirth.
    • Provides tips for protecting pelvic floor muscles during the early postnatal period and reinforce the recommended healthy bladder habit.
    Wrap-up To give respondents a final opportunity to seek support and guidance • Ask the participants to summarize what was covered in today’s sessions.
    • Encourage and remind the participants to continue practicing PFME in daily life.
    Characteristic Baseline comparison
    		 Baseline comparison among completer (n=122) (included in primary analysis)
    		 Baseline comparison among completer and non-completer
    Intervention group (n=85) Control group (n=85) P-value Intervention group (n=63) Control group (n=59) P-value Non-completer (n=48) P-value
    Age (y)* 30.3±5.1 30.9±5.3 0.429 31.0±4.6 31.3±5.5 0.782 29.4±5.5 0.046
    Body mass index (kg/m2)* 25.7±5.6 27.5±6.2 0.049 26.2±5.5 27.4±6.4 0.256 26.1±5.9 0.482
    Gestational (wk)* 18.8±2.2 18.8±2.0 0.912 18.7±2.2 18.9±1.8 0.434 18.7±2.3 0.870
    Salary (RM)* 2,760.0±1,415.9 2,804.9±1,407.5 0.864 2,820.6±1,342.8 2,793.2±1,412.8 0.926 2,695.4±1,542.1 0.704
    Ethnicity† 0.133 0.448 1.00
      Malay 75 (88.2) 67 (78.8) 55 (87.3) 46 (78.0) 41 (85.4)
    Chinese 3 (3.5) 5 (5.9) 2 (3.2) 4 (6.8) 2 (4.2)
    Indian 4 (4.7) 12 (14.1) 4 (6.3) 8 (13.6) 4 (8.3)
    Others 3 (3.5) 1 (1.2) 2 (3.2) 1 (1.7) 1 (2.1)
    Education‡ 0.093 0.025 0.463
    Primary 1 (1.2) 2 (2.4) 0 2 (1.6) 1 (2.1)
    Secondary 26 (30.6) 38 (44.7) 17 (27.0) 26 (44.1) 21 (43.8)
    College/university 58 (68.2) 45 (52.9) 46 (73.0) 31 (52.5) 26 (54.2)
    Occupational† 0.251 0.131 0.222
    Public sector employed 31 (36.5) 24 (28.2) 27 (42.9) 17 (28.8) 11 (22.9)
    Private sector employed 24 (28.2) 24 (28.2) 17 (27.0) 19 (32.2) 12 (25.0)
    Self-employed 5 (5.9) 3 (3.5) 4 (6.3) 1 (1.7) 3 (6.3)
    Housewife 23 (27.1) 34 (40.0) 14 (22.2) 22 (37.3) 21 (43.8)
    Others 2 (2.4) - 1 (1.6) 0 1 (0.6)
    Parity‡ 0.752 0.701 0.022
    Nulliparous 33 (38.8) 31 (36.5) 19 (30.2) 20 (33.9) 25 (52.1)
    Multiparous ≥1 52 (61.2) 54 (63.5) 44 (69.8) 39 (66.1) 23 (47.9)
    History of delivery‡ 0.612 0.938 0.065
    SVD 35 (41.2) 39 (45.9) 31 (49.2) 29 (49.2) 14 (29.2)
    LSCS 9 (10.6) 11 (12.9) 8 (12.7) 7 (11.9) 5 (10.4)
    Both SVD & LSCS 8 (9.4) 4 (4.7) 5 (7.9) 3 (5.1) 4 (8.3)
    Nil 33 (38.8) 31 (36.5) 19 (32.0) 20 (33.9) 25 (52.1)
    Pre-pregnancy UI‡ 0.679 0.649 0.251
    Yes 15 (17.6) 13 (15.3) 13 (20.6) 10 (16.9) 5 (10.4)
    No 70 (82.4) 72 (84.7) 50 (79.4) 49 (83.1) 43 (89.6)
    History of smoking† 0.682 0.366 0.322
    Yes 4 (4.7) 2 (2.4) 4 (6.3) 1 (1.7) 1 (2.1)
    No 81 (95.3) 82 (96.5) 59 (93.7) 58 (98.3) 46 (95.8)
    Currently smoking - 1 (1.2) 0 0 1 (2.1)
    Health history†
    Nil 59 (69.4) 57 (67.1) 0.990 43 (68.3) 41 (69.5) 0.856 32 (66.7) 0.950
    UTI 3× per year 2 (2.4) 3 (3.5) 2 (3.2) 2 (3.4) 1 (2.1)
    Heart problem 2 (2.4) 3 (3.5) 1 (1.6) 2 (3.4) 2 (4.2)
    Asthma 7 (8.2) 8 (9.4) 4 (6.3) 6 (10.2) 5 (10.4)
    Depression 1 (1.2) - 1 (1.6) 0 -
    Others 14 (16.5) 14 (16.5) 12 (19.0) 8 (13.6) 8 (16.7)
    Constipation‡ 0.153 0.233 0.827
    Never 27 (31.8) 34 (40.0) 20 (31.7) 25 (42.4) 16 (33.3)
    Seldom (less than 1× monthly) 31 (36.5) 27 (31.8) 23 (36.5) 19 (32.2) 16 (33.3)
    Sometimes (less than 2× weekly) 17 (20.0) 21 (24.7) 12 (19.0) 13 (22.0) 13 (27.1)
    Often (at least 3× weekly) 10 (11.8) 3 (3.5) 8 (12.7) 2 (3.4) 3 (6.3)
    Type of UI† 0.486 0.660 0.064
    Nil 50 (58.8) 58 (68.2) 34 (54.0) 37 (62.7) 37 (77.1)
    SUI 30 (35.3) 24 (28.2) 25 (39.7) 19 (32.2) 10 (20.8)
    UUI 5 (5.9) 3 (3.5) 4 (6.3) 3 (5.1) 1 (2.1)
    Continence status‡ 0.200 0.328 0.022
    Continence 50 (58.8) 58 (68.2) 34 (54.0) 37 (62.7) 37 (77.1)
    Incontinence 35 (41.2) 27 (31.8) 29 (46.0) 22 (37.3) 11 (22.9)
    Outcome measure and timepoints IG (n=63) CG (n=59) Difference or OR between group (95% CI) P-value
    Knowledge
      Baseline* 7.27±1.57 7.07±1.62 0.20 (-0.95 to 1.35) 1.000
    Early third trimester change from baseline† -7.29±0.76 -1.25±0.62 6.04 (4.11 to 7.96) <0.001
    Late third trimester change from baseline† -7.32±0.75 -1.61±0.65 5.71 (3.77 to 7.65) <0.001
    Early postnatal change from baseline† -8.14±0.69 -1.56±0.64 6.58 (4.74 to 8.43) <0.001
    Late third trimester change from early third trimester† -0.03±0.16 -0.36±0.27 -0.32 (-0.93 to 0.28) 0.295
    Early postnatal change from early third trimester† -0.86±0.38 -0.31±0.29 0.55 (-0.39 to1.49) 0.249
    Early postnatal change from late third trimester† -0.83±0.34 0.05±0.12 0.88 (0.17 to 1.58) 0.015
    Attitude
    Baseline* 30.73±8.83 30.45±8.87 0.28 (-0.54 to 1.10) 1.000
    Early third trimester change from baseline† -3.02±0.91 0.58±0.67 3.60 (1.37 to 5.82) 0.002
    Late third trimester change from baseline† -2.56±0.97 0.59±0.59 3.15 (0.92 to 5.3) 0.006
    Early postnatal change from baseline† -3.43±0.94 0.54±0.61 3.97 (1.78 to 6.16) <0.001
    Late third trimester change from early third trimester† 0.46±0.55 0.02±0.42 -0.44 (-1.81 to 0.92) 0.524
    Early postnatal change from early third trimester† -0.41±0.66 -0.03±0.46 0.38 (-1.21 to 1.96) 0.639
    Early postnatal change from late third trimester† -0.87±0.36 -0.05±0.14 0.82 (0.06 to 1.58) 0.034
    Practice
    Baseline* 9.07±2.05 8.62±2.23 0.45 (-0.54 t0 1.46) 1.000
    Early third trimester change from baseline† -6.40±0.74 -1.00±0.50 5.40 (3.65 to 7.15) <0.001
    Late third trimester change from baseline† -7.35±0.78 -1.42±0.53 5.93 (4.08 to 7.78) <0.001
    Early postnatal change from baseline† -7.97±0.74 -1.39±0.52 6.58 (4.82 to 8.34) <0.001
    Late third trimester change from early third trimester† -0.95±0.43 -0.42±0.23 0.53 (-0.43 to -0.49) 0.279
    Early postnatal change from early third trimester† -1.57±0.51 -0.39±0.25 1.18 (0.07 to 2.30) 0.038
    Early postnatal change from late third trimester† -0.62±0.33 0.03±0.08 0.65 (0.00 to 1.31) 0.051
    Self-efficacy
    Baseline* 36.50±4.75 34.18±4.99 2.33 (-13.59 to 18.25) 1.000
    Early third trimester change from baseline† -34.53±3.53 1.46±2.86 35.99 (27.08 to 44.90) <0.001
    Late third trimester change from baseline† -38.51±3.48 0.54±3.16 39.05 (29.83 to 48.26) <0.001
    Early postnatal change from baseline† -40.02±3.25 1.91±3.26 41.93 (32.91 to 50.96) <0.001
    Late third trimester change from early third trimester† -3.97±2.18 -0.92±1.88 3.06 (-2.59 to 8.70) 0.289
    Early postnatal change from early third trimester† -5.49±2.40 0.46±2.03 5.94 (-0.22 to 12.11) 0.059
    Early postnatal change from late third trimester† -1.51±1.12 1.38±0.77 2.89 (0.22 to 5.55) 0.034
    Severity of urinary incontinence
    Baseline* 2.97±0.67 2.79±0.72 0.18 (-0.38 to 0.74) 1.000
    Early third trimester change from baseline† 0.30±0.31 -0.81±0.37 -1.12 (-2.07 to -0.16) 0.022
    Late third trimester change from baseline† 0.81±0.34 -1.29±0.39 -2.10 (-3.11 to -1.09) <0.001
    Early postnatal change from baseline† 0.57±0.36 -1.97±0.45 -2.54 (-3.67 to -1.41) <0.001
    Late third trimester change from early third trimester† 0.51±0.16 -0.47±0.21 -0.98 (-1.50 to 0.47) <0.001
    Early postnatal change from early third trimester† 0.27±0.24 -1.15±0.31 -1.42 (-2.19 to -0.66) <0.001
    Early postnatal change from late third trimester† -0.24±0.18 -0.68±0.25 -0.44 (-1.04 to 0.16) <0.001
    Self-reported urinary incontinence
    Baseline‡ 39.7 (25) 33.9 (20) 0.508
    Early third trimester change from baseline§ 7.9 (5) 13.6 (8) 0.83 (0.48 to 1.43) 0.499
    Late third trimester change from baseline§ 14.3 (9) 16.9 (10) 0.63 (0.33 to 1.18) 0.149
    Early postnatal change from baseline§ 22.2 (14) 27.1 (16) 0.601 (0.29 to 1.24) 0.170
    Late third trimester change from early third trimester§ 6.4 (4) 3.3 (2) 0.76 (0.55 to 1.05) 0.099
    Early postnatal change from early third trimester§ 14.3 (9) 13.5 (8) 0.725 (0.44 to 1.19) 0.206
    Early postnatal change from late third trimester§ 7.9 (5) 10.2 (6) 0.961 (0.66 to 1.40) 0.834
    Outcome measure and timepoints IG (n=85) CG (n=85) Difference or OR between group (95% CI) P-value
    Knowledge
      Baseline* 6.78±0.93 6.52±0.96 -0.26 (-1.19 to 0.68) 0.590
    Early third trimester change from baseline† -7.27±0.60 -2.96±0.55 4.31 (2.72 to 5.90) <0.001
    Late third trimester change from baseline† -7.56±0.61 -3.38±0.58 4.18 (2.53 to 5.83) <0.001
    Early postnatal change from baseline† -6.39±0.67 -5.80±0.68 0.60 (-1.27 to 2.46) 0.530
    Late third trimester change from early third trimester† -0.30±0.16 -0.43±0.23 -0.13 (-0.67 to 0.41) 0.641
    Early postnatal change from early third trimester† 0.87±0.43 -2.84±0.66 -3.71 (-5.26 to -2.17) <0.001
    Early postnatal change from late third trimester† 1.17±0.43 -2.41±0.66 -3.58 (-5.14 to -2.03) <0.001
    Attitude
    Baseline* 30.36±4.75 30.12±4.75 -0.24 (-1.04 to 0.56) 0.559
    Early third trimester change from baseline† -2.88±0.76 -0.14±0.58 2.74 (0.87 to 4.62) 0.004
    Late third trimester change from baseline† -2.52±0.80 -0.15±0.55 2.37 (0.48 to 4.27) 0.014
    Early postnatal change from baseline† -3.71±0.57 -3.40±0.56 0.31 (-1.26 to 1.88) 0.701
    Late third trimester change from early third trimester† 0.36±0.52 -0.01±0.39 -0.37 (-1.64 to -0.91) 0.570
    Early postnatal change from early third trimester† -0.82±0.67 -3.26±0.63 -2.44 (-4.24 to 0.64) 0.008
    Early postnatal change from late third trimester† -1.18±0.73 -3.25±0.62 -2.07 (-3.93 to -0.20) 0.030
    Practice
    Baseline* 8.73±1.16 8.33±1.26 -0.40 (-1.09 to 0.28) 0.249
    Early third trimester change from baseline† -6.48±0.56 -1.83±0.46 4.65 (3.24 to 6.07) <0.001
    Late third trimester change from baseline† -7.46±0.61 -2.22±0.52 5.24 (3.68 to 6.81) <0.001
    Early postnatal change from baseline† -5.20±0.55 -5.13±0.51 0.07 (-1.41 to 1.55) 0.928
    Late third trimester change from early third trimester† -0.98±0.33 -0.39±0.27 0.59 (-2.24 to 1.43) 0.164
    Early postnatal change from early third trimester† 1.28±0.48 -3.30±0.49 -4.58 (-5.93 to -3.24) <0.001
    Early postnatal change from late third trimester† 2.26±0.56 -2.91±0.62 -5.18 (-6.81 to -3.68) <0.001
    Self-efficacy
    Baseline* 34.00±3.81 32.79±3.77 -1.22 (-10.14 to 7.71) 0.789
    Early third trimester change from baseline† -34.43±3.06 -5.83±2.91 28.60 (20.32 to 36.88) <0.001
    Late third trimester change from baseline† -38.91±3.11 -6.69±3.21 32.22 (23.46 to 40.99) <0.001
    Early postnatal change from baseline† -18.19±3.29 12.98±3.27 5.22 (-3.87 to 14.31) 0.260
    Late third trimester change from early third trimester† -4.49±1.55 -0.86±1.59 3.62 (-0.73 to 7.98) 0.103
    Early postnatal change from early third trimester† 16.23±2.09 -7.15±2.84 -23.38 (-30.29 to 16.47) <0.001
    Early postnatal change from late third trimester† 20.72±2.34 -6.29±2.86 -27.00 (-34.24 to -19.77) <0.001
    Severity of urinary incontinence
    Baseline* 2.73±0.54 2.39±0.55 -0.34 (-0.92 to 0.23) 0.238
    Early third trimester change from baseline† -0.13±0.28 -0.99±0.35 -0.86 (-1.74 to 0.02) 0.054
    Late third trimester change from baseline† 0.17±0.35 -1.50±0.37 -1.67 (-2.66 to -0.68) 0.001
    Early postnatal change from baseline† -2.00±0.43 -3.04±0.42 -1.04 (-2.21 to 0.14) 0.084
    Late third trimester change from early third trimester† 0.30±0.17 -0.51±0.20 -0.81 (-1.33 to -0.29) 0.002
    Early postnatal change from early third trimester† -1.87±0.32 -2.05±0.38 -0.17 (-1.14 to 0.79) 0.724
    Early postnatal change from late third trimester† -2.18±0.27 -1.54±0.37 0.64 (-0.25 to 1.52) 0.160
    Self-reported urinary incontinence
    Baseline‡ 41.2 (35) 31.8 (27) - 0.202
    Early third trimester change from baseline§ 12.9 (11) 17.6 (15) 0.78 (0.37 to 1.69) 0.535
    Late third trimester change from baseline§ 15.3 (13) 21.2 (18) 0.77 (0.29 to 2.07) 0.604
    Early postnatal change from baseline§ 15.3 (13) 10.6 (9) 1.26 (0.45 to 3.55) 0.659
    Late third trimester change from early third trimester§ 2.4 (2) 3.5 (3) 0.95 (0.45 to 2.02) 0.898
    Early postnatal change from early third trimester§ 2.4 (2) 7.1 (-6) 1.59 (0.55 to 4.60) 0.392
    Early postnatal change from late third trimester§ 0 10.6 (-9) 1.68 (0.65 to 4.39) 0.286
    Outcome measure and timepoints IG CG Parameters Estimated mean difference or OR between groups (95% CI) P-value
    Knowledge
      Baseline* (n=170, IG:85, CG:85) 6.96±1.23 6.88±1.25 Early third trimester change from baseline† 6.48 (4.53 to 8.43) <0.001
    Early third trimester* (n=112, IG: 58, CG:54) 14.85±1.30 8.29±1.29 Late third trimester change from baseline† 5.78 (3.72 to 7.83) <0.001
    Late third trimester* (n=82, IG:42, CG:40) 14.65±1.31 8.78±1.29 Early postnatal change from baseline† 9.02 (6.99 to 11.05) <0.001
    Early postnatal* (n=21, IG:10, CG:11) 17.18±1.23 8.07±1.29 Late third trimester change from early third trimester† -0.88 (-2.09 to 0.34) 0.156
    Early postnatal change from early third trimester† 1.72 (-1.30 to 4.75) 0.264
    Early postnatal change from late third trimester† 2.52 (-0.65 to 5.69) 0.119
    Attitude
    Baseline* (n=170, IG:85, CG:85) 30.48±6.49 30.41±6.50 Early third trimester change from baseline† 3.92 (1.53 to 6.30) 0.001
    Early third trimester* (n=112, IG: 58, CG:54) 33.85±6.46 29.85±6.50 Late third trimester change from baseline† 2.65 (0.06 to 5.24) 0.045
    Late third trimester* (n=82, IG:42, CG:40) 32.56±6.40 29.84±6.53 Early postnatal change from baseline† 6.59 (3.81 to 9.38) <0.001
    Early postnatal* (n=21, IG:10, CG:11) 37.28±6.38 30.61±6.55 Late third trimester change from early third trimester† -2.10 (-4.24 to 0.03) 0.054
    Early postnatal change from early third trimester† 1.21 (-2.32 to 4.73) 0.503
    Early postnatal change from late third trimester† 3.27 (-0.41 to 6.95) 0.082
    Practice
    Baseline* (n=170, IG:85, CG:85) 8.82±1.74 8.64±1.81 Early third trimester change from baseline† 5.96 (4.18 to 7.73) <0.001
    Early third trimester* (n=112, IG: 58, CG:54) 15.85±1.86 9.71±1.77 Late third trimester change from baseline† 6.56 (4.49 to 8.64) <0.001
    Late third trimester* (n=82, IG:42, CG:40) 16.91±1.95 10.17±1.83 Early postnatal change from baseline† 8.10 (5.83 to 10.38) <0.001
    Early postnatal* (n=21, IG:10, CG:11) 17.76±2.07 9.48±1.82 Late third trimester change from early third trimester† 0.43 (-1.10 to -1.97) 0.579
    Early postnatal change from early third trimester† 2.38 (-0.58 to 5.34) 0.115
    Early postnatal change from late third trimester† 1.96 (-1.31 to 5.23) 0.239
    Self-efficacy
    Baseline* (n=170, IG:85, CG:85) 34.07±4.51 32.93±4.36 Early third trimester change from baseline† 45.86 (35.82 to 55.90) <0.001
    Early third trimester* (n=112, IG: 58, CG:54) 73.08±3.32 32.55±4.53 Late third trimester change from baseline† 46.66 (34.86 to 58.47) <0.001
    Late third trimester* (n=82, IG:42, CG:40) 79.38±3.84 32.38±4.79 Early postnatal change from baseline† 4.89 (-2.35 to 12.12) <0.001
    Early postnatal* (n=21, IG:10, CG:11) 73.47±4.24 25.67±5.45 Late third trimester change from early third trimester† 39.39 (30.64 to 48.12) 0.189
    Early postnatal change from early third trimester† 7.17 (-3.90 to 18.23) 0.204
    Early postnatal change from late third trimester† 6.38 (-6.47 to 19.23) 0.330
    Severity of urinary incontinence
    Baseline* (n=170, IG:85, CG:85) 2.83±0.60 2.69±0.62 Early third trimester change from baseline† -1.16 (-2.07 to -0.15) 0.024
    Early third trimester* (n=112, IG: 58, CG:54) 2.56±0.62 3.59±0.73 Late third trimester change from baseline† -2.40 (-3.58 to -1.23) <0.001
    Late third trimester* (n=82, IG:42, CG:40) 1.98±0.66 4.25±0.72 Early postnatal change from baseline† -3.81 (-6.36 to -1.26) 0.003
    Early postnatal* (n=21, IG:10, CG:11) 3.57±1.10 7.24±1.10 Late third trimester change from early third trimester† -1.28 (-2.15 to -0.41) 0.004
    Early postnatal change from early third trimester† -2.14 (-4.88 to -0.60) 0.126
    Early postnatal change from late third trimester† -0.89 (-3.69 to 1.91) 0.532
    Self-reported urinary incontinence
    Baseline‡ (n=170, IG:85, CG:85) 41.2 (35) 31.8 (27) Early third trimester change from baseline§ 0.81 (0.46 to 1.44) 0.481
    Early third trimester‡ (n=112, IG: 58, CG:54) 55.2 (32) 48.1 (26) Late third trimester change from baseline§ 0.54 (0.26 to 1.10) 0.090
    Late third trimester‡ (n=82, IG:42, CG:40) 52.4 (22) 57.5 (23) Early postnatal change from baseline§ 0.54 (0.07 to 4.13) 0.555
    Early postnatal‡ (n=21, IG:10, CG:11) 70 (7) 81.8 (9) Late third trimester change from early third trimester§ 0.74 (0.42 to 1.30) 0.297
    Early postnatal change from early third trimester§ 0.67 (0.10 to 4.48) 0.679
    Early postnatal change from late third trimester§ 1.04 (0.13 to 8.53) 0.973
    Table 1. The content of pelvic floor muscle exercises intervention and delivery of the intervention

    PMME, pelvic floor muscle exercise; UI, urinary incontinence.

    Table 2. Baseline characteristics of the respondents and comparison between the study groups

    Values are presented as mean±standard deviation or number of respondents (%). P-value significant at P<0.05.

    SVD, spontaneous vaginal delivery; LSCS, lower segment cesarean section; UI, urinary incontinence; SUI, stress urinary incontinence; UTI, urinary tract infection; UUI, urge urinary incontinence.

    By t-test.

    By Fisher’s exact test.

    By chi-square test.

    Table 3. Generalized estimating equations models parameter for pelvic floor muscle exercise intervention effect on primary and secondary outcome measures among completer

    Values are presented as estimated mean±standard error or % (number of respondents). P-value significant P<0.05.

    IG, intervention group; CG, control group; OR, odds ratio; CI, confidence interval.

    The estimates mean difference at baseline and

    the changes over time between group (expressed as Exp [β] or exponentiation of the beta coefficient) based on generalized estimating equation model: time, group, and group by time interaction adjusted for baseline value and covariates.

    Percentage difference present between study groups at baseline was calculated using the chi-square test.

    Percentage changes over time between group expressed as OR based on generalized estimating equation model: time, group, covariate, and group by time interaction. Percentage change in number of respondents between two timepoints: a positive value is an increase; a negative value is a decrease.

    Table 4. Generalized estimating equations models parameter for pelvic floor muscle exercise intervention effect on primary and secondary outcome measures based on intention-to-treat with multiple imputation

    Values are presented as estimated mean±standard error or % (number of respondents). P-value significant P<0.05.

    IG, intervention group; CG, control group; OR, odd ratio; CI, confidence interval.

    The estimates mean difference at baseline and

    the changes over time between group (expressed as Exp [β] or exponentiation of the beta coefficient) based on generalized estimating equation model: time, group, and group by time interaction adjusted for baseline value and covariates.

    Percentage difference present between study groups at baseline was calculated using the chi-square test.

    Percentage changes over time between group expressed as OR based on generalized estimating equation model: time, group, covariate, and group by time interaction. Percentage change in number of respondents between two timepoints: a positive value is an increase; a negative value is a decrease.

    Table 5. Generalized estimating equations models parameter for pelvic floor muscle exercise intervention effect on primary and secondary outcome measures based on complete cases or all available data from baseline to end of follow-up without imputation

    Values are presented as estimated mean±standard error or % (number of respondents). P-value significant P<0.05.

    IG, intervention group; CG, control group; OR, odd ratio; CI, confidence interval.

    The estimated mean and standard error at each timepoint in the intervention and control group and

    the changes over time between group (expressed as Exp [β] or exponentiation of the beta coefficient) based on generalized estimating equation model: time, group, and group by time interaction adjusted for baseline value and covariates.

    Percentage (number of respondents) present at each timepoint was calculated using descriptive analysis.

    Percentage changes over time between group expressed as OR based on generalized estimating equation model: time, group, covariate, and group by time interaction.

    Table 1.

    Table 2.

    Table 3.

    Table 4.

    Table 5.

    Korean J Fam Med : Korean Journal of Family Medicine

    ABOUT

    ARTICLE CATEGORY

    BROWSE ARTICLES 

    AUTHOR INFORMATION 

    © The Korean Academy of Family Medicine.
    TOP